Search Results 211-220 of 16801 for Fibronolytic
The purpose of this study to test the feasibility and safety for autologous (from your own body) skin cells that are manufactured into stem cells of cardiac ...
Mayo Clinic researchers study genetics, causes, diagnostic tests and treatment options for cystic fibrosis. You may have the opportunity to participate in ...
This condition, passed down in families, causes damage to the lungs, digestive system and other organs. Learn about screening and newer treatments.
This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...
Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...
Definitively determine the therapeutic benefit of the intensive treatment relative to the standard treatment in the proportion of patients with death and ...
About this study. The purpose of this study is to evaluate the impact of the highly effective CFTR modulator, elexacaftor/tezacaftor/ivacaftor (Trikafta) on ...
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
About this study. DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.